Endo International reports $17.99 million net loss for January

By Sarah Lizee

Olympia, Wash., March 26 – Endo International plc reported a $17.99 million net loss for January on zero gross income/sales, according to its monthly operating report filed Tuesday with the U.S. Bankruptcy Court for the Southern District of New York.

In comparison, the company reported a $9.02 million net loss for December on zero gross income/sales.

The cash balance at the end of January was negative $1.76 million, down from $1.58 million at the end of December.

Endo is a Dublin-based specialty pharmaceutical company that filed bankruptcy on Aug. 16, 2022. The Chapter 11 case number is 22-22549.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.